271 related articles for article (PubMed ID: 31703099)
1. Inactive USP14 and inactive UCHL5 cause accumulation of distinct ubiquitinated proteins in mammalian cells.
Chadchankar J; Korboukh V; Conway LC; Wobst HJ; Walker CA; Doig P; Jacobsen SJ; Brandon NJ; Moss SJ; Wang Q
PLoS One; 2019; 14(11):e0225145. PubMed ID: 31703099
[TBL] [Abstract][Full Text] [Related]
2. Ubiquitinated proteins promote the association of proteasomes with the deubiquitinating enzyme Usp14 and the ubiquitin ligase Ube3c.
Kuo CL; Goldberg AL
Proc Natl Acad Sci U S A; 2017 Apr; 114(17):E3404-E3413. PubMed ID: 28396413
[TBL] [Abstract][Full Text] [Related]
3. The deubiquitinating enzyme Usp14 allosterically inhibits multiple proteasomal activities and ubiquitin-independent proteolysis.
Kim HT; Goldberg AL
J Biol Chem; 2017 Jun; 292(23):9830-9839. PubMed ID: 28416611
[TBL] [Abstract][Full Text] [Related]
4. Targeted inhibition of the deubiquitinating enzymes, USP14 and UCHL5, induces proteotoxic stress and apoptosis in Waldenström macroglobulinaemia tumour cells.
Chitta K; Paulus A; Akhtar S; Blake MK; Caulfield TR; Novak AJ; Ansell SM; Advani P; Ailawadhi S; Sher T; Linder S; Chanan-Khan A
Br J Haematol; 2015 May; 169(3):377-90. PubMed ID: 25691154
[TBL] [Abstract][Full Text] [Related]
5. Impact of Losing hRpn13 Pru or UCHL5 on Proteasome Clearance of Ubiquitinated Proteins and RA190 Cytotoxicity.
Osei-Amponsa V; Sridharan V; Tandon M; Evans CN; Klarmann K; Cheng KT; Lack J; Chari R; Walters KJ
Mol Cell Biol; 2020 Aug; 40(18):. PubMed ID: 32631902
[TBL] [Abstract][Full Text] [Related]
6. Ubiquitin-specific protease 14 regulates c-Jun N-terminal kinase signaling at the neuromuscular junction.
Vaden JH; Bhattacharyya BJ; Chen PC; Watson JA; Marshall AG; Phillips SE; Wilson JA; King GD; Miller RJ; Wilson SM
Mol Neurodegener; 2015 Jan; 10():3. PubMed ID: 25575639
[TBL] [Abstract][Full Text] [Related]
7. Computational and biochemical studies of isothiocyanates as inhibitors of proteasomal cysteine deubiquitinases in human cancer cells.
Ahmed ZSO; Li X; Li F; Cheaito HA; Patel K; Mosallam EM; Elbargeesy GAEH; Dou QP
J Cell Biochem; 2018 Nov; 119(11):9006-9016. PubMed ID: 30015387
[TBL] [Abstract][Full Text] [Related]
8. Insulin Suppresses Ubiquitination via the Deubiquitinating Enzyme Ubiquitin-Specific Protease 14, Independent of Proteasome Activity in H4IIEC3 Hepatocytes.
Kamoshita K; Ishii KA; Tahira Y; Kikuchi A; Abuduwaili H; Tajima-Shirasaki N; Li Q; Takayama H; Matsumoto K; Takamura T
J Pharmacol Exp Ther; 2023 Apr; 385(1):5-16. PubMed ID: 36328485
[TBL] [Abstract][Full Text] [Related]
9. A ubiquitinome analysis to study the functional roles of the proteasome associated deubiquitinating enzymes USP14 and UCH37.
van der Wal L; Bezstarosti K; Demmers JAA
J Proteomics; 2022 Jun; 262():104592. PubMed ID: 35489684
[TBL] [Abstract][Full Text] [Related]
10. Trimming of ubiquitin chains by proteasome-associated deubiquitinating enzymes.
Lee MJ; Lee BH; Hanna J; King RW; Finley D
Mol Cell Proteomics; 2011 May; 10(5):R110.003871. PubMed ID: 20823120
[TBL] [Abstract][Full Text] [Related]
11. UBL domain of Usp14 and other proteins stimulates proteasome activities and protein degradation in cells.
Kim HT; Goldberg AL
Proc Natl Acad Sci U S A; 2018 Dec; 115(50):E11642-E11650. PubMed ID: 30487212
[TBL] [Abstract][Full Text] [Related]
12. Targeting proteasomal deubiquitinases USP14 and UCHL5 with b-AP15 reduces 5-fluorouracil resistance in colorectal cancer cells.
Ding W; Wang JX; Wu JZ; Liu AC; Jiang LL; Zhang HC; Meng Y; Liu BY; Peng GJ; Lou EZ; Mao Q; Zhou H; Tang DL; Chen X; Liu JB; Shi XP
Acta Pharmacol Sin; 2023 Dec; 44(12):2537-2548. PubMed ID: 37528233
[TBL] [Abstract][Full Text] [Related]
13. Proteasome-associated cysteine deubiquitinases are molecular targets of environmental optical brightener compounds.
Castro I; Ekinci E; Huang X; Cheaito HA; Ahn YH; Olivero-Verbel J; Dou QP
J Cell Biochem; 2019 Aug; 120(8):14065-14075. PubMed ID: 30963630
[TBL] [Abstract][Full Text] [Related]
14. Treatment with b-AP15 to Inhibit UCHL5 and USP14 Deubiquitinating Activity and Enhance p27 and Cyclin E1 for Tumors with
Jiang ZY; Hong J; Zhang JH; Wang XF; Ma YS; Xiong ZX; Sun HR; Cheng C; Xie BZ; Liu JB; Ouyang YG; Fu D
Technol Cancer Res Treat; 2022; 21():15330338221119745. PubMed ID: 35971329
[No Abstract] [Full Text] [Related]
15. In vitro analysis of proteasome-associated USP14 activity for substrate degradation and deubiquitylation.
Muniyappan S; Lee BH
Methods Enzymol; 2019; 619():249-268. PubMed ID: 30910023
[TBL] [Abstract][Full Text] [Related]
16. USP14 deubiquitinates proteasome-bound substrates that are ubiquitinated at multiple sites.
Lee BH; Lu Y; Prado MA; Shi Y; Tian G; Sun S; Elsasser S; Gygi SP; King RW; Finley D
Nature; 2016 Apr; 532(7599):398-401. PubMed ID: 27074503
[TBL] [Abstract][Full Text] [Related]
17. Facilitated Tau Degradation by USP14 Aptamers via Enhanced Proteasome Activity.
Lee JH; Shin SK; Jiang Y; Choi WH; Hong C; Kim DE; Lee MJ
Sci Rep; 2015 Jun; 5():10757. PubMed ID: 26041011
[TBL] [Abstract][Full Text] [Related]
18. Proteasomal deubiquitinase UCH37 inhibits degradation of β-catenin and promotes cell proliferation and motility.
Li Z; Zhou L; Jiang T; Fan L; Liu X; Qiu X
Acta Biochim Biophys Sin (Shanghai); 2019 Mar; 51(3):277-284. PubMed ID: 30726867
[TBL] [Abstract][Full Text] [Related]
19. Ubiquitin-specific protease 14 is a new therapeutic target for the treatment of diseases.
Wang D; Ma H; Zhao Y; Zhao J
J Cell Physiol; 2021 May; 236(5):3396-3405. PubMed ID: 33135160
[TBL] [Abstract][Full Text] [Related]
20. Autoregulation of the 26S proteasome by in situ ubiquitination.
Jacobson AD; MacFadden A; Wu Z; Peng J; Liu CW
Mol Biol Cell; 2014 Jun; 25(12):1824-35. PubMed ID: 24743594
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
